A detailed history of Qube Research & Technologies LTD transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 71,701 shares of PMVP stock, worth $124,759. This represents 0.0% of its overall portfolio holdings.

Number of Shares
71,701
Holding current value
$124,759
% of portfolio
0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.51 - $2.21 $108,268 - $158,459
71,701 New
71,701 $116,000
Q3 2023

Nov 13, 2023

SELL
$6.01 - $8.93 $282,085 - $419,138
-46,936 Reduced 42.32%
63,976 $392,000
Q2 2023

Aug 14, 2023

SELL
$3.94 - $6.27 $546,383 - $869,498
-138,676 Reduced 55.56%
110,912 $694,000
Q1 2023

May 15, 2023

BUY
$4.77 - $9.16 $558,385 - $1.07 Million
117,062 Added 88.33%
249,588 $1.19 Million
Q4 2022

Feb 14, 2023

BUY
$8.17 - $12.95 $893,691 - $1.42 Million
109,387 Added 472.74%
132,526 $1.15 Million
Q3 2022

Nov 14, 2022

BUY
$11.4 - $17.18 $263,784 - $397,528
23,139 New
23,139 $275,000
Q1 2022

May 09, 2022

SELL
$14.86 - $23.55 $269,976 - $427,856
-18,168 Closed
0 $0
Q4 2021

Feb 01, 2022

BUY
$19.99 - $30.24 $363,178 - $549,400
18,168 New
18,168 $420,000

Others Institutions Holding PMVP

About PMV Pharmaceuticals, Inc.


  • Ticker PMVP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,622,600
  • Market Cap $79.4M
  • Description
  • PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...
More about PMVP
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.